Mendeleyev et al., 1997 - Google Patents
Structural specificity and tumoricidal action of methyl-3, 5-diiodo-4-(4'-methoxyphenoxy) benzoate (DIME)Mendeleyev et al., 1997
- Document ID
- 4346326425958010889
- Author
- Mendeleyev J
- Young L
- Kirsten E
- Vidair C
- Hakam A
- Zhen J
- Bauer P
- Buki K
- Kun E
- Publication year
- Publication venue
- International journal of oncology
External Links
Snippet
Seventeen homologs and analogs of methyl-3, 5-diiodo-4 (4'-methoxyphenoxy) benzoate (DIME), a hormonally inactive analog of thyroid hormones, have been synthesized and their antitumor activity scored by assaying their antitumorigenic effect in vivo following …
- 230000002476 tumorcidal 0 title description 10
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/11—Aldehydes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O-metal, -CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6017958A (en) | Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity | |
| US5736576A (en) | Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity | |
| US8389544B2 (en) | Isoquinolone compounds as subtype-selective agonists for melatonin receptors MT1 and MT2 | |
| Meyskens Jr et al. | Inhibition of human melanoma colony formation by retinoids | |
| Stogniew et al. | Electrophilic reactions of acyl-linked glucuronides. Formation of clofibrate mercapturate in humans. | |
| WO1997046228A9 (en) | Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity | |
| SHEN et al. | Synthesis and cytotoxicity evaluation of some 8‐hydroxyquinoline derivatives | |
| Polossek et al. | 6-Alkyl-12-formylindolo [2, 1-a] isoquinolines. Syntheses, estrogen receptor binding affinities, and stereospecific cytostatic activity | |
| Hecht et al. | Potent mammary carcinogenicity in female CD rats of a fjord region diol-epoxide of benzo [c] phenanthrene compared to a bay region diol-epoxide of benzo [a] pyrene | |
| JP2010502644A (en) | Treatment methods using WRN binding molecules | |
| KR20170070140A (en) | Method for treating cancer | |
| US5015666A (en) | Triarylcyclopropanes as antiestrogens and antitumor agents | |
| Bertilsson et al. | Stereospecific hydroxylation of nortriptyline in man in relation to interindividual differences in its steady-state plasma level | |
| TW202321240A (en) | Salt of GLP-1R agonist compound, and preparation method therefor and pharmaceutical use thereof | |
| Biberger et al. | 1-Benzyl-2-phenylindole-and 1, 2-diphenylindole-based antiestrogens. Estimation of agonist and antagonist activities in transfection assays | |
| Marrazzo et al. | Antiproliferative activity of phenylbutyrate ester of haloperidol metabolite II [(±)-MRJF4] in prostate cancer cells | |
| Mendeleyev et al. | Structural specificity and tumoricidal action of methyl-3, 5-diiodo-4-(4'-methoxyphenoxy) benzoate (DIME) | |
| EP2271332B1 (en) | Use of compounds in the treatment of tauopathy | |
| WO2008102397A2 (en) | Colchicine derivatives, process for their preparation and use in the medical field | |
| Schneider et al. | 2-Phenylindenes. Development of a new mammary tumor-inhibiting antiestrogen by combination of estrogenic side effect-lowering structural elements | |
| Antony et al. | In-vitro cell line Models and Assay methods to study the Anti-diabetic Activity | |
| WO2007125196A1 (en) | Type 1, 4-naphtoquinone compounds, compositions comprising them and use of these compounds as anti-cancer agents | |
| Đorđević et al. | Immunomodulatory activity of marine natural products: Synthesis, spectral characterization and toxicity assessment of natural and related synthetic iodinated tyramides | |
| Nagasawa et al. | A note on the deacylation of the carcinogen 2-acetamidofluorene and related compounds by rat liver and intestine | |
| Aoki et al. | In situ photoaffinity labeling of the target protein for lembehyne A, a neuronal differentiation inducer |